Latest Geographic Expansion News

AFT Pharmaceuticals has reported record revenue of NZD 208 million for FY25, driven by strong Australasian sales and a recovery in Asia and international markets. The company is targeting NZD 300 million in revenue by FY27, supported by an expanded R&D pipeline and ongoing geographic diversification.

Comms Group Limited has inked a binding agreement to acquire TasmaNet, a leading Tasmanian communications provider, significantly expanding its network assets and customer base. This strategic move is expected to lift Comms Group’s proforma revenue to around $75 million and EBITDA to $9-10 million annually.

Humm Group reported a solid 10% increase in assets under management to $5.3 billion for 3Q25, maintaining stable margins while advancing a new hybrid loan product and IT platform modernization.

HeraMED reports strong Q1 FY25 progress with 4,282 registered users on its HeraCARE platform, a new collaboration with Garmin Health, and advancing commercial deals in the US and Europe. Early clinical data suggests improved maternal outcomes and operational efficiencies.

Bridge SaaS Limited reports a 7% increase in NDIS participant numbers through its majority-owned Brightside, while advancing regional expansion and targeting cash flow positivity by refining operational efficiencies.

XRF Scientific has reported record half-year revenue and profit for FY25, driven by robust demand from mining and industrial sectors and strategic acquisitions that bolster its market position.

SRG Global Limited has delivered a robust half-year performance to December 2024, marked by significant revenue and profit growth alongside a strategic acquisition that bolsters its market footprint.

Smart Parking Limited has reported robust H1 FY25 results, underpinned by a strategic acquisition of Peak Parking LP and a fully underwritten $45 million equity raise to fund its US expansion.

Smart Parking Limited has reported a robust half-year performance with a 20% increase in revenue and a 70% rise in net profit, driven by international expansion and operational growth across multiple markets.

Cochlear Limited posted a 6% increase in HY25 sales revenue driven by strong implant sales but anticipates FY25 profits at the lower end of guidance due to declining services revenue and rising cloud investments.

Cochlear Limited posted a 5% increase in sales revenue to $1.17 billion for the half year ended December 2024, driven by strong cochlear and acoustic implant growth despite a decline in Services revenue. The company anticipates FY25 underlying net profit at the lower end of guidance amid increased cloud investments and prepares for new product launches.

Cochlear Limited has reported a robust half-year performance with a 7% increase in underlying net profit and an 8% rise in interim dividends, driven by strong sales in cochlear and acoustic implants despite a decline in services revenue.